 Pfizer Inc dropped its pursuit of British rival AstraZeneca PLC leaving both drug makers to overcome aging pipelines and market pressures alone  Pfizer had been chasing AstraZeneca since November in an effort to create the worlds biggest pharmaceutical company Pfizer last proposed a deal valued at  billion But AstraZeneca was able to run out the clock on Mondays deadline under UK takeover rules for reaching an agreement Under those rules Pfizer could submit another offer for AstraZeneca in six months 